VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+34.89%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
495
New
Increased
Reduced
Closed

Top Buys

1
+$2.11M
2
+$2.09M
3
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

1
+$2.13M
2
+$2.13M
3
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANNX icon
276
Annexon
ANNX
$888M
$304K 0.08%
54,866
+1,339
PTGX icon
277
Protagonist Therapeutics
PTGX
$6.4B
$301K 0.08%
2,860
+70
APGE icon
278
Apogee Therapeutics
APGE
$6.19B
$298K 0.08%
3,538
+87
CELC icon
279
Celcuity
CELC
$6.48B
$296K 0.08%
2,589
+61
SMMT icon
280
Summit Therapeutics
SMMT
$13.6B
$294K 0.08%
15,519
+378
GHRS icon
281
GH Research
GHRS
$1.65B
$294K 0.08%
20,920
+512
BCAX
282
Bicara Therapeutics
BCAX
$1.43B
$293K 0.08%
14,755
+360
DNLI icon
283
Denali Therapeutics
DNLI
$3.34B
$291K 0.08%
15,166
+371
AMLX icon
284
Amylyx Pharmaceuticals
AMLX
$1.6B
$289K 0.08%
20,815
+508
MRCC
285
DELISTED
Monroe Capital Corp
MRCC
$288K 0.08%
62,628
-5,712
RCKT icon
286
Rocket Pharmaceuticals
RCKT
$335M
$288K 0.08%
80,438
+1,964
PGEN icon
287
Precigen
PGEN
$1.55B
$286K 0.08%
73,899
+1,804
SRRK icon
288
Scholar Rock
SRRK
$5.91B
$286K 0.08%
5,816
+140
MAIN icon
289
Main Street Capital
MAIN
$4.76B
$285K 0.08%
5,380
-951
OMER icon
290
Omeros
OMER
$799M
$284K 0.08%
26,865
+653
CYTK icon
291
Cytokinetics
CYTK
$10.4B
$284K 0.08%
4,303
+56
RAPP
292
Rapport Therapeutics
RAPP
$1.89B
$282K 0.08%
9,007
+218
CMPX icon
293
Compass Therapeutics
CMPX
$429M
$280K 0.08%
52,846
+1,290
GLUE icon
294
Monte Rosa Therapeutics
GLUE
$1.67B
$275K 0.08%
16,718
+408
STOK icon
295
Stoke Therapeutics
STOK
$1.93B
$274K 0.08%
8,418
+204
RCUS icon
296
Arcus Biosciences
RCUS
$3.19B
$274K 0.08%
12,664
+308
MBX
297
MBX Biosciences
MBX
$1.5B
$273K 0.08%
9,131
+221
ZYME icon
298
Zymeworks
ZYME
$1.85B
$268K 0.07%
10,702
+261
IRWD icon
299
Ironwood Pharmaceuticals
IRWD
$588M
$267K 0.07%
76,169
+1,858
IMTX icon
300
Immatics
IMTX
$1.57B
$267K 0.07%
27,159
+662
10 11
12
13 14